Immuno-oncology

Immuno-oncology is a relatively recent and rapidly advancing field of research focused on co-opting the immune system to fight a cancer. Here, you will find our comprehensive range of resources and products to support your immuno-oncology research. These include high-quality antibodies, ELISA kits, native and recombinant proteins and peptides, and multiplex kits, all designed to help you achieve reliable and reproducible results. In addition, you will find our collection of guides and in-depth articles for valuable insights into immune checkpoint inhibitors, CAR-T cell therapy, the tumor microenvironment, and other key areas of study.

Our catalog features a wide range of primary and secondary antibodies, extensively validated for use in immuno-oncology applications. Our recombinant monoclonal antibodies are validated across multiple applications and tissue types, including multi-normal and multi-disease tissue types as standard, ensuring excellent specificity and sensitivity with minimal batch-to-batch variability. Our enhanced-validated antibodies build upon our extensive validation platform by examining antibodies in over 600 tissue types from several diseases and animals. Additionally, we offer ELISA kits for the accurate quantification of biomarkers, native and recombinant proteins and peptides for functional studies, and multiplex kits for the simultaneous detection of multiple targets.

Whether you are investigating immune responses in cancer, assessing novel cancer immunotherapies, or studying tumor immunogenicity, our products and resources are designed to support your research at every step. Enhance your immuno-oncology experiments with our reliable, high-quality tools.

With our resources below, you can gain the knowledge and tools necessary to achieve reliable and reproducible results.

Related immuno-oncology content